Optimizing pain treatment interventions (OPTI): A pilot randomized controlled trial of collaborative care to improve chronic pain management and opioid safety-Rationale, methods, and lessons learned.


Journal

Contemporary clinical trials
ISSN: 1559-2030
Titre abrégé: Contemp Clin Trials
Pays: United States
ID NLM: 101242342

Informations de publication

Date de publication:
02 2019
Historique:
received: 12 09 2018
revised: 27 11 2018
accepted: 16 12 2018
pubmed: 21 12 2018
medline: 14 4 2020
entrez: 21 12 2018
Statut: ppublish

Résumé

Veterans seeking care in VA medical facilities have high rates of chronic pain, which often co-occur with mental health and substance use disorders, including prescription opioid misuse. The overall goal of the Optimizing Pain Treatment Interventions (OPTI) study was to pilot a 12-week Collaborative Care intervention to improve opioid safety, chronic pain disability, and use of non-pharmacological pain management strategies in veterans in VA primary care. Between November 2014 and January 2017, 100 veteran patients with chronic pain and high-risk prescription opioid use (e.g., high-dose therapy, early refills, etc.) were enrolled and completed an initial one-hour study visit with a primary care provider (PCP) within 4 weeks of enrollment. Study PCPs were guided by a web-based opioid management decision support program and templated notes in the VA electronic medical record. After assessment and education, study PCPs used Shared Decision-Making to formulate a Pain Care Plan aligned with a participant's personal values and goals. After the initial visit, patients randomized to Collaborative Care received one Motivational Interviewing (MI) session with a Care Manager followed by 3 Care Manager-delivered brief telephone MI sessions at 6, 8, and 12 weeks to reinforce Pain Care Plans; patients randomized to an Attention Control condition met with a Care Manager briefly, followed by 3 brief scripted telephone psychoeducation sessions at 6, 8, and 12 weeks. Masked evaluators assessed outcomes at baseline, end of intervention (12 weeks), and after eight weeks of no contact (20 weeks). We present study rationale, detailed methods, preliminary results and lessons learned.

Identifiants

pubmed: 30572163
pii: S1551-7144(18)30560-3
doi: 10.1016/j.cct.2018.12.006
pmc: PMC6392081
mid: NIHMS1517646
pii:
doi:

Substances chimiques

Analgesics, Opioid 0

Types de publication

Clinical Trial Protocol Journal Article Randomized Controlled Trial Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

76-85

Subventions

Organisme : NCCIH NIH HHS
ID : R34 AT008319
Pays : United States

Informations de copyright

Published by Elsevier Inc.

Références

Gen Hosp Psychiatry. 2012 Sep-Oct;34(5):450-9
pubmed: 22632925
J Gen Intern Med. 2003 Jan;18(1):9-16
pubmed: 12534758
Clin Psychol Rev. 2001 Aug;21(6):857-77
pubmed: 11497210
Pain Med. 2010 Apr;11(4):575-85
pubmed: 20202142
J Pain. 2017 Mar;18(3):308-318
pubmed: 27908840
Arch Intern Med. 2006 Oct 23;166(19):2087-93
pubmed: 17060538
J Pain. 2009 Feb;10(2):113-30
pubmed: 19187889
JAMA. 2012 Mar 7;307(9):940-7
pubmed: 22396516
Addiction. 2002 Sep;97(9):1183-94
pubmed: 12199834
Clin J Pain. 2008 Jul-Aug;24(6):521-7
pubmed: 18574361
CMAJ. 2006 May 23;174(11):1589-94
pubmed: 16717269
Pain. 2017 May;158(5):833-839
pubmed: 28240996
Clin Rehabil. 2009 Apr;23(4):352-61
pubmed: 19237435
JAMA. 2009 Mar 25;301(12):1242-52
pubmed: 19318652
JAMA. 1999 Nov 10;282(18):1737-44
pubmed: 10568646
JAMA. 2018 Mar 6;319(9):872-882
pubmed: 29509867
Behav Sleep Med. 2011 Dec 28;10(1):6-24
pubmed: 22250775
Pain. 2010 Sep;150(3):390-400
pubmed: 20334973
Implement Sci. 2010 Oct 25;5:82
pubmed: 20973988
Pain. 2004 Dec;112(3):372-80
pubmed: 15561393
J Gen Intern Med. 2006 Jun;21(6):652-5
pubmed: 16808752
Ann Acad Med Singapore. 1994 Mar;23(2):129-38
pubmed: 8080219
Pain. 2004 Dec;112(3):254-66
pubmed: 15561380
JAMA. 1995 Apr 5;273(13):1026-31
pubmed: 7897786
Pain Med. 2010 Nov;11(11):1688-97
pubmed: 21044259
MMWR Morb Mortal Wkly Rep. 2016 Dec 30;65(50-51):1445-1452
pubmed: 28033313
Implement Sci. 2009 Aug 07;4:50
pubmed: 19664226
Eur J Pain. 2014 Jul;18(6):835-43
pubmed: 24921073
BMJ. 2012 Jan 27;344:e256
pubmed: 22286508
Behav Res Ther. 1996 Aug;34(8):669-73
pubmed: 8870294
J Gen Intern Med. 2012 Oct;27(10):1361-7
pubmed: 22618581
Implement Sci. 2010 Apr 12;5:26
pubmed: 20385018
J Am Med Inform Assoc. 2004 Sep-Oct;11(5):368-76
pubmed: 15187064
J Gen Intern Med. 2013 Jan;28(1):41-50
pubmed: 22868947
Arch Intern Med. 2011 Jan 10;171(1):23-31
pubmed: 21220657
Soc Sci Med. 1991;32(6):705-14
pubmed: 2035047
MMWR Recomm Rep. 2016 Mar 18;65(1):1-49
pubmed: 26987082
Pain. 2007 Jul;130(1-2):144-56
pubmed: 17493754
Behav Res Ther. 2001 Jul;39(7):787-800
pubmed: 11419610
J Pain Symptom Manage. 2006 Oct;32(4):342-51
pubmed: 17000351
J Gen Intern Med. 2011 Sep;26(9):965-71
pubmed: 21562923
J Pain. 2011 Mar;12(3):352-9
pubmed: 20851057
J Gen Intern Med. 2009 Jun;24(6):733-8
pubmed: 19418100
JAMA Intern Med. 2017 May 1;177(5):611-612
pubmed: 28288245
J Gen Intern Med. 2001 Sep;16(9):606-13
pubmed: 11556941
Gen Hosp Psychiatry. 2008 Mar-Apr;30(2):93-9
pubmed: 18291290
Annu Rev Clin Psychol. 2005;1:91-111
pubmed: 17716083

Auteurs

Karen H Seal (KH)

San Francisco Veterans Affairs Health Care System, United States; University of California, San Francisco, San Francisco, CA, United States. Electronic address: Karen.Seal@va.gov.

Brian Borsari (B)

San Francisco Veterans Affairs Health Care System, United States; University of California, San Francisco, San Francisco, CA, United States.

Jennifer Tighe (J)

San Francisco Veterans Affairs Health Care System, United States.

Beth E Cohen (BE)

San Francisco Veterans Affairs Health Care System, United States; University of California, San Francisco, San Francisco, CA, United States.

Kevin Delucchi (K)

University of California, San Francisco, San Francisco, CA, United States.

Benjamin J Morasco (BJ)

Center to Improve Veteran Involvement in Care, VA Portland Health Care System, United States; Department of Psychiatry, Oregon Health and Science University, United States.

Yongmei Li (Y)

San Francisco Veterans Affairs Health Care System, United States.

Emily Sachs (E)

San Francisco Veterans Affairs Health Care System, United States.

Linda Abadjian (L)

San Francisco Veterans Affairs Health Care System, United States.

Erin C Watson (EC)

San Francisco Veterans Affairs Health Care System, United States; University of California, San Francisco, San Francisco, CA, United States.

Jennifer K Manuel (JK)

San Francisco Veterans Affairs Health Care System, United States; University of California, San Francisco, San Francisco, CA, United States.

Lea Vella (L)

San Francisco Veterans Affairs Health Care System, United States; University of California, San Francisco, San Francisco, CA, United States.

Jodie Trafton (J)

VA Palo Alto Health Care System, Center for Innovation to Implementation (Ci2i), United States; Program Evaluation and Resource Center (PERC), VA Office of Mental Health Operations, United States.

Amanda Midboe (A)

VA Palo Alto Health Care System, Center for Innovation to Implementation (Ci2i), United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH